Physician profile
Benjamin Bryan Browning
NPI 1790075844
$5,389.79
in general payments reported to CMS, 2019-2025
12 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $67.60 · 2022: $674 · 2023: $154 · 2024: $3,124 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,399 · Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,398.66 |
| Food and Beverage | $1,061.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tricoast Surgical Solutions LLC | $2,077.33 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,663.05 | 2019-2024 | Comprehensive Shoulder System, Comprehensive |
| Smith+Nephew, INC. | $488.21 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Arthrex, INC. | $431.49 | 2023-2024 | |
| Astellas Pharma US INC | $124.93 | 2019 | |
| Amgen INC. | $122.79 | 2019 | |
| Radius Health, INC. | $111.49 | 2019 | |
| Vericel Corporation | $100.68 | 2019 | |
| Novo Nordisk INC | $91.73 | 2019 | |
| Stryker Corporation | $83.35 | 2019-2024 | Aequalis Flex Revive, Tornier Perform Reversed Glenoid |
| Depuy Synthes Sales INC. | $67.60 | 2020 | |
| Janssen Pharmaceuticals, INC | $27.14 | 2024 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.